S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Investors Face September 14 Deadline in GPGI Securities Fraud Lawsuit

Investors who purchased Class A common stock in GPGI, Inc.—formerly known as CompoSecure, Inc.—between November 3, 2025, and May 6, 2026, face a looming September 14, 2026, deadline to apply as lead plaintiff in a pending class action lawsuit alleging securities fraud.

Investors Face September 14 Deadline in GPGI Securities Fraud Lawsuit
Photo: Bio & News

The litigation centers on claims that the company misled shareholders regarding the financial health and strategic value of its acquisition of Husky. According to the complaint, executives allegedly overstated the value of the acquisition while failing to disclose that Husky was not on track to meet its revenue and Adjusted EBITDA targets. The lawsuit contends that the deal was primarily motivated by the desire to generate fees for Resolute Holdings and individual defendants rather than creating long-term value for investors.

Investors are not required to take immediate action to remain part of the class, as no class has been formally certified. However, those wishing to serve as a lead plaintiff must file a motion with the court by the September 14 cutoff. Rosen Law Firm, which is representing the action, notes that investors may choose their own counsel or remain absent members until the class is certified. Prospective participants can access filing details through the firm’s website or by contacting Phillip Kim at 866-767-3653.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!